Olga Slater

1.5k total citations
30 papers, 546 citations indexed

About

Olga Slater is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Olga Slater has authored 30 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Olga Slater's work include Sarcoma Diagnosis and Treatment (11 papers), Tumors and Oncological Cases (10 papers) and Histiocytic Disorders and Treatments (3 papers). Olga Slater is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Tumors and Oncological Cases (10 papers) and Histiocytic Disorders and Treatments (3 papers). Olga Slater collaborates with scholars based in United Kingdom, Netherlands and France. Olga Slater's co-authors include Veronica A. Kinsler, Neil J. Sebire, Neil Bulstrode, Thomas S. Jacques, Darren Hargrave, Janet Shipley, Anna Thomas, Sam Loughlin, Jane Chalker and Rodger Palmer and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Investigative Dermatology.

In The Last Decade

Olga Slater

26 papers receiving 540 citations

Peers

Olga Slater

ONCOL

PRM

GENET

Sarah A. Jackson United States

Emil Anthony T. Say United States

A C McCartney United Kingdom

E. Meyen Belgium

Nathalie Burri Switzerland

J. Distler Germany

Jane Chalker United Kingdom

Andréia Bufalino Brazil

P Theunissen Netherlands

Fiona Connell United Kingdom

Sarah A. Jackson United States

Olga Slater

116 ×0.4

ONCOL

215 ×1.0

87 ×0.6

PRM

118 ×0.9

GENET

113 ×1.2

Citations per year, relative to Olga Slater Olga Slater (= 1×) peers Sarah A. Jackson

Countries citing papers authored by Olga Slater

Since Specialization

Citations

This map shows the geographic impact of Olga Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Slater more than expected).

Fields of papers citing papers by Olga Slater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Slater. The network helps show where Olga Slater may publish in the future.

Co-authorship network of co-authors of Olga Slater

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Slater. A scholar is included among the top collaborators of Olga Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Slater. Olga Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schoot, Reineke A., M. Hol, Véronique Minard-Colin, et al.. (2025). Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma. European Journal of Endocrinology. 192(1). 25–33.

Donadieu, Jean, D. A. Evseev, Caroline Hutter, et al.. (2025). Long-term off-label MAPK inhibitor therapy in children with severe/refractory Langerhans cell histiocytosis: An international observational study of 277 cases.. Journal of Clinical Oncology. 43(16_suppl). 10011–10011.

Hol, M., Daniel J. Indelicato, Olga Slater, et al.. (2023). Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study. Pediatric Blood & Cancer. 70(8). e30412–e30412. 1 indexed citations

Scheltinga, Sheila Terwisscha van, Timothy Rogers, Naima Smeulders, et al.. (2023). Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma. Cancers. 15(2). 449–449. 8 indexed citations

Hol, M., Reineke A. Schoot, Olga Slater, et al.. (2022). Patient‐reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician‐graded adverse events—A multicenter study using the FACE‐Q Craniofacial module. Cancer Medicine. 12(4). 4739–4750. 6 indexed citations

Barnett, S., Rebecca Rees, Olga Slater, et al.. (2022). Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series. Pediatric Blood & Cancer. 69(7). e29722–e29722. 3 indexed citations

Gaze, Mark N., Olga Slater, Peter Hoskin, et al.. (2022). Bladder function after conservative surgery and high‐dose rate brachytherapy for bladder–prostate rhabdomyosarcoma. Pediatric Blood & Cancer. 69(8). e29574–e29574. 8 indexed citations

Slater, Olga, J. Gains, Anna Kelsey, et al.. (2021). Localised rhabdomyosarcoma in infants (<12 months) and young children (12–36 months of age) treated on the EpSSG RMS 2005 study. European Journal of Cancer. 160. 206–214. 13 indexed citations

Talenti, Giacomo, Caroline D. Robson, Carmela Russo, et al.. (2021). Magnetic resonance features and cranial nerve involvement in pediatric head and neck rhabdomyosarcomas. Neuroradiology. 63(11). 1925–1934. 8 indexed citations

10.

Bisogno, Gianni, Véronique Minard‐Colin, Julia Daragjati, et al.. (2021). Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group. Pediatric Blood & Cancer. 69(2). e29376–e29376. 5 indexed citations

11.

Sadiq, Zaid, et al.. (2019). Melanotic neuroectodermal tumour of infancy: Refining the surgical approach. International Journal of Oral and Maxillofacial Surgery. 48(10). 1307–1312. 14 indexed citations

12.

Panagopoulou, Paraskevi, et al.. (2019). Challenges in the Diagnosis of Medulloblastoma Recurrence at an Unusual Site in a Patient With Prader-Willi Syndrome. Journal of Pediatric Hematology/Oncology. 42(5). e381–e384. 1 indexed citations

13.

Muthialu, Nagarajan, Kieran McHugh, & Olga Slater. (2018). Anterior Mediastinal Mass in a Child—Known but Rare Entity. Indian Journal of Surgery. 80(3). 288–289. 2 indexed citations

14.

Kinsler, Veronica A., Patricia O’Hare, Thomas S. Jacques, Darren Hargrave, & Olga Slater. (2017). MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children. British Journal of Cancer. 116(8). 990–993. 38 indexed citations

15.

Schoot, Reineke A., M. Hol, Johannes H. M. Merks, et al.. (2017). Facial asymmetry in head and neck rhabdomyosarcoma survivors. Pediatric Blood & Cancer. 64(10). 11 indexed citations

16.

Schoot, Reineke A., Olga Slater, Marta López‐Yurda, et al.. (2015). Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long‐term follow‐up study. Clinical Otolaryngology. 41(3). 276–283. 12 indexed citations

17.

Grotel, Martine van, et al.. (2013). Distant Metastatic Spread of Molecularly Proven Infantile Fibrosarcoma of the Chest in a 2-month-old Girl. Journal of Pediatric Hematology/Oncology. 36(3). 231–233. 7 indexed citations

18.

Kinsler, Veronica A., Anna Thomas, Miho Ishida, et al.. (2013). Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS. Journal of Investigative Dermatology. 133(9). 2229–2236. 196 indexed citations

19.

Slater, Olga & Janet Shipley. (2007). Clinical relevance of molecular genetics to paediatric sarcomas. Journal of Clinical Pathology. 60(11). 1187–1194. 35 indexed citations

20.

Anderson, John, Olga Slater, Kieran McHugh, P.G. Duffy, & Jon Pritchard. (2002). Response Without Shrinkage in Bilateral Wilms Tumor: Significance of Rhabdomyomatous Histology. Journal of Pediatric Hematology/Oncology. 24(1). 31–34. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact